Frank Barry
Impact in
Papers in
- Genetics 93
- Mesenchymal stem cell research 92
- Virus-based gene therapy research 13
- Rheumatology 41
- Osteoarthritis Treatment and Mechanisms 40
- Co-authors
- Mary MurphyBernard P. MahonTimothy O’BrienRaymond BoyntonKaren EnglishJennifer RyanStephen C. BeckErnst B. Hunziker
- Journals
- Stem Cell Research & Therapy (10 papers)Cytotherapy (8 papers)Osteoarthritis and Cartilage (8 papers)Stem Cells and Development (5 papers)Stem Cells (5 papers)
- Partner nations
- IrelandUnited StatesUnited Kingdom
In The Last Decade
Frank Barry
172 papers receiving 15.6k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Genetics 8.8k
- Urology 2.3k
- Rheumatology 4.1k
- Biomaterials 2.1k
- Surgery 5.0k
Countries citing papers authored by Frank Barry
This map shows the geographic impact of Frank Barry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Barry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Barry more than expected).
Fields of papers citing papers by Frank Barry
This network shows the impact of papers produced by Frank Barry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Barry. The network helps show where Frank Barry may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Frank Barry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 6 | |
| 3 | 2023 | 8 | |
| 4 | 2022 | 7 | |
| 5 | Cell-based strategies for IVD repair: clinical progress and translational obstacles Hit paper breakdown → | 2021 | 194 |
| 6 | 2019 | 67 | |
| 7 | 2019 | 69 | |
| 8 | 2016 | 7 | |
| 9 | 2015 | 31 | |
| 10 | 2013 | 73 | |
| 11 | 2012 | 23 | |
| 12 | 2011 | 3 | |
| 13 | 2010 | 26 | |
| 14 | 2009 | 118 | |
| 15 | 2009 | 17 | |
| 16 | 2009 | 6 | |
| 17 | 2008 | 39 | |
| 18 | 2008 | 43 | |
| 19 | 2006 | 136 | |
| 20 | 2005 | 154 |
About Frank Barry
Frank Barry is a scholar working on Genetics, Rheumatology, Urology, Immunology and Allergy and Biomaterials, having authored 176 papers that have together received 16.0k indexed citations. Recurring topics across this work include Mesenchymal stem cell research (92 papers), Osteoarthritis Treatment and Mechanisms (40 papers), Tissue Engineering and Regenerative Medicine (23 papers), Electrospun Nanofibers in Biomedical Applications (15 papers), Periodontal Regeneration and Treatments (15 papers), RNA Interference and Gene Delivery (14 papers), Virus-based gene therapy research (13 papers) and Proteoglycans and glycosaminoglycans research (13 papers). The work is most often cited by research in Genetics (8.8k citations), Urology (2.3k citations), Rheumatology (4.1k citations), Biomaterials (2.1k citations) and Surgery (5.0k citations). Frank Barry has collaborated with scholars based in Ireland, United States and United Kingdom. Frequent co-authors include Mary Murphy, Bernard P. Mahon, Timothy O’Brien, Raymond Boynton, Karen English, Jennifer Ryan, Stephen C. Beck, Ernst B. Hunziker, David J. Fink and Beishan Liu. Their work appears in journals such as Stem Cell Research & Therapy, Cytotherapy, Osteoarthritis and Cartilage, Stem Cells and Development and Stem Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.